Relative political unknown Noda to take over 'daunting task': NYT

NEW YORK, Aug. 29 Kyodo

Meanwhile, The Wall Street Journal said that Noda, who has advocated a temporary tax hike to finance reconstruction from the March 11 disaster, is seen by economists and political analysts as a ''steady hand.'' His stance was welcomed by the bond market, which saw a downgrading of Japanese sovereign debt last week, it said.The two papers said Noda will likely see improvements in the running of Diet affairs because of his willingness to cooperate with the Liberal Democratic Party and other opposition forces, which are capable of blocking most bills due to their control of the House of Councillors.of Japan, The New York Times reported Monday.''Mr. Noda will take over the daunting tasks of leading Japan's recovery from the deadly earthquake and the clean-up of radiation from the stricken Fukushima Daiichi nuclear plant, while also overcoming the challenges of two decades of economic stagnation, an aging population and the rise of neighboring China,'' the daily said in its electronic version.It said that Noda, who lacks a large power base within the party and was seen running a distant third before the DPJ's lawmakers voted Monday, scored a ''surprise victory'' and that the DPJ was apparently signaling an ''effort to move beyond deep divisions that have undermined the party.''Japanese Finance Minister Yoshihiko Noda, who has been elected to lead the ruling Democratic Party of Japan, is a relative political unknown who faces heavy responsibility as the next prime minister

But on the diplomatic front, Noda could increase frictions with China and other Asian countries because of his position that Japan's wartime leaders were not war criminals, the reports said.

Toshiba’s Aquilion ONE Dynamic Volume and Perfusion Imaging Technologies Improve Head and Neck Tumor Diagnoses

Toshiba Showcases the Aquilion ONE at the American Society of Head and Neck Radiology’s Annual Meeting

“The advanced imaging capabilities of the Aquilion ONE not only capture high-quality images of anatomy but also changes in that anatomy over time,” said Joseph Cooper, director, CT Business Unit, Toshiba. “For patients requiring perfusion imaging to determine a head or neck tumor’s malignancy, the Aquilion ONE allows a physician to see blood flow in real time, enabling greater visualization and more complete diagnosis for improved patient care.”Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).Also at ASHNR, Toshiba will sponsor a lunch-and-learn presentation, “320 Detector Row Head and Neck Imaging: Unique Benefits including Functional Imaging,” presented by Dr. Keith Peters, UF College of Medicine associate professor of radiology and neurological surgery. The presentation will take place on Thursday, September 8, 2011, at 12:00 p.m. PT, Hotel del Coronado, San Diego.Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.About ToshibaAbout Toshiba America Medical Systems, Inc.Unlike any other CT system available, the Aquilion ONE covers up to 16 cm of anatomy using 320 ultra-high-resolution 0.5 mm detector elements. With the Aquilion ONE, clinicians can use its advanced perfusion imaging capabilities to visualize and quantify blood flow, as well as determine the stage, location and treatment path for patients.About Toshiba Medical Systems CorporationTUSTIN, Calif. -- When diagnosing and planning treatment for head or neck tumors, clinicians require a CT system that is able to identify diseases and malignancies with high accuracy. Toshiba America Medical Systems, Inc.’s AquilionTM ONE CT system has the unique ability to show dynamic blood flow and real-time function, improving diagnostic accuracy, while making imaging safer by limiting radiation dose. Toshiba will showcase these capabilities during the American Society of Head and Neck Radiology’s (ASHNR) annual meeting, September 7 – 11, in San Diego.

Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).

Aeolus to Present at Stifel Nicolaus' Annual Healthcare Conference

Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in developing a platform of a new class of broad-spectrum catalytic antioxidant compounds as medical countermeasures to radiation exposure to develop them in oncology indications, today announced that it will be presenting at the Stifel Nicolaus Annual Healthcare Conference in Boston. Russell Skibsted, the Company's Chief Financial Officer, will be presenting a corporate update, including an overview of its recent contract with the Biomedical Advanced Research and Development Authority (BARDA), with options valued at $118 million.

Company Contact Russell Skibsted Chief Financial Officer Aeolus Pharmaceuticals, Inc. 949-481-9821Forward-Looking Statements The statements in this press release that are not purely statements of historical fact are forward-looking statements. Such statements include, but are not limited to, those relating to Aeolus' product candidates, as well as its proprietary technologies and research programs. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Aeolus' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Important factors that could cause results to differ include risks associated with uncertainties of progress and timing of clinical trials, scientific research and product development activities, difficulties or delays in development, testing, obtaining regulatory approval, the need to obtain funding for pre-clinical and clinical trials and operations, the scope and validity of intellectual property protection for Aeolus' product candidates, proprietary technologies and their uses, and competition from other biopharmaceutical companies. Certain of these factors and others are more fully described in Aeolus' filings with the Securities and Exchange Commission, including, but not limited to, Aeolus' amended Annual Report on Form 10-K/A for the year ended September 30, 2010. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.About Aeolus Pharmaceuticals Aeolus Pharmaceuticals is developing a new class of catalytic antioxidant compounds that protects healthy tissue from the damaging effects of radiation. Its first compound, AEOL 10150, is being developed for oncology indications, where it is used in combination with radiation therapy. It is also being developed, with funding by the US Government, as a medical countermeasure against chemical and radiological weapons, where its initial target indications are as a protective agent against the effects of acute radiation syndrome and delayed effects of acute radiation exposure. Aeolus' strategy is to leverage the substantial investment in toxicology, manufacturing, and preclinical and clinical studies made by US Government agencies in AEOL 10150, including the contract with BARDA valued, with options, at up to $118 million, to efficiently develop the compound for use in oncology.

Company Contact Russell Skibsted Chief Financial Officer Aeolus Pharmaceuticals, Inc. 949-481-9821

Top 10 home efficiency tips; SAVING ENERGY

HOUSEHOLD energy costs have doubled in six years and the latest round of increases will add around pounds 200 extra to your bills each year.

The Heating Helpline has released 10 tips to help cut energy costs.8) Appliances left on 'standby' can waste up to pounds 100 of energy a year. Unplug to save money. 9) Turn your washing machine down to 40-30C and cut energy usage by 40%.6) Draught proofing doors, windows and attic entrances by sealing gaps saves energy; as do heavy, well-fitted curtains over windows and doors.2) Fitting a jacket to the boiler could save over pounds 50 a year. 3) Most people's thermostats are set higher than they need to be to keep comfortably warm. Set room thermostats to no more than 21C (70F).7) Heat rises so upgraded insulation in the roof space will reduce heat loss. 27cm of insulation could save you up to pounds 150 a year.4) Consider fitting a programmable thermostat that lets you choose the time you want your heating on and the temperature for all seven days of the week.5) Thermostatic radiator valves (costing pounds 8 each) let you control the temperature in each room to avoid wasting energy.1) The hot water cylinder thermostat should be set at 60C (140F). Any higher is a waste of energy, but any lower carries a risk of legionella.

10) When using the kettle only boil the amount of water you need.

Runner finishes near bottom of American Discovery Trail event, and

All runners have their own motivation, especially those who travel long distances.

"My big goal was to PR, to be in the top three and to break 3 hours," said Howard, who earned a doctorate in physical therapy from Northern Arizona. "I ran this race last year and finished second, so I was happy to improve my time by 6 minutes and to win it."Mudry, 24, and Nichols recently returned from three months of shooting footage in Kenya for a documentary titled "Where Dreams Don't Fade," a film that captures the flavor of what fuels Kenyan runners to become world-class athletes."I'm not fast, and I might be one of the last people in, but I'm lucky," Smith said. "This is my way of flipping cancer off. Every day I get to train and run, it's a good day. Everybody races their own race."Three years ago, those two words blindsided the former psychotherapist, who lived in Denver at the time, as ovarian cancer had invaded her body. Monday, some two years after being declared cancer free - thanks to 30 rounds of radiation, 12 cycles of chemotherapy and three surgeries - Smith didn't put much stock into the time it took to complete more than 13 miles.Alexis Smith, of Colorado Springs, has plenty of motivation, summed up by two words expressed as she crossed the finish line in 350th place Monday in the half marathon version of the American Discovery Trail event that concluded at America the Beautiful Park.Note quite 3 hours, but she'll take it.For Martin Mudry, his race motivation was eclipsing the marathon course mark set last year by roommate Alex Nichols, a Colorado College graduate.Time has a funny way of adjusting one's perspective."The idea was to follow where people pursue their dreams for a long period of time," Mudry said. "Kenyans do that. They have a huge level of self confidence. They have a dream of being a champion, and they go after it for five or 10 years, even without having a job, and keep pursuing it even if it's not going well. That's a big part of what we show.""I decided to go after his ghost today," said Mudry, who completed the 26.2-mile trek from Palmer Lake in 2 hours, 32 minutes and 53 seconds.He didn't, but winning the overall title took away any hint of disappointment.Monday's race went well, too, for Sharon Howard of Aurora, who was the first female to finish the marathon(3:01:01).Mudry, who spent one year at Colorado College before finishing his undergraduate work at Macalester College in St. Paul, Minn., said he hopes to launch the film early next year.

"My big goal was to PR, to be in the top three and to break 3 hours," said Howard, who earned a doctorate in physical therapy from Northern Arizona. "I ran this race last year and finished second, so I was happy to improve my time by 6 minutes and to win it."

New Reimbursement Codes for Intra-Operative Radiation Therapy (IORT)

Reimbursement Codes effective January 1, 2012 will cover cancer patients for additional treatment options

“We are pleased that the AMA and ASTRO supported these codes for electron IORT. By approving new CPT codes for electron IORT procedures, patients will have greater access to a single, two minute, radiation treatment during surgery. These patients will benefit from a reduction of up to seven weeks of external beam radiation, also reducing the toxicity of their treatment and providing a quick return their normal lives.” said John Powers, Chief Executive Officer of IntraOp. “We anticipate that these new codes will increase patient awareness and availability of electron IORT to cancer patients throughout the United States.”IntraOp Medical Corporation provides innovative technology solutions for the treatment and eradication of cancer. The IntraOp Mobetron is a patented, self-shielded, mobile, linear accelerator that allows hospitals to provide electron IORT in existing operating rooms at the time of surgery. Mobetron benefits include: increased survival rates, better local tumor control, shorter treatment cycles, and fewer side effects. Centers of excellence in North America, Europe and Asia, use the Mobetron as a vital part of their comprehensive cancer program. The Mobetron is used to effectively treat over 20 different cancer indications.For more information on IntraOp Medical Corporation, please visit www.intraopmedical.comAbout IntraOp

For more information on IntraOp Medical Corporation, please visit www.intraopmedical.com

Curtiss-Wright Controls Electronic Systems Introduces New 3U OpenVPX Smart Power Supply

Curtiss-Wright Controls Electronic Systems (CWCES), a business group of Curtiss-Wright Controls and a leading designer and manufacturer of rugged deployed subsystems for the aerospace, defense and commercial markets, has introduced a new 3U OpenVPX (VITA 62) and VPX (VITA 48.2) Smart Power Supply . This small form factor, rugged power supply module provides up to 279W of power to mission critical OpenVPX systems. Designed for demanding deployed military applications, the CWCES Smart Power Supply includes advanced features such as an integrated Nuclear Event Detector (NED) and crowbar for radiation tolerant applications, and a holdup circuitry for full protection against MIL-STD-704 and MIL-STD-1275 transients. This open architecture smart power supply module speeds and simplifies the integration and maintenance of intelligent rugged power supplies into applications such as ground vehicles, fixed wing aircraft and rotorcraft, shipboard equipment, and integrated modular systems.

Note: All trademarks are property of their respective owners.About Curtiss-Wright Controls, Inc. Headquartered in Charlotte, N.C., Curtiss-Wright Controls is the motion control segment of Curtiss-Wright Corporation. With manufacturing facilities around the world, Curtiss-Wright Controls is a leading technology-based organization providing niche motion control products, subsystems and services internationally for the aerospace and defense markets. For more information, visit www.cwcontrols.com ."Our new 3U OpenVPX power supply provides system integrators with a rugged, compact high performance power supply able to survive the harshest military environments, while providing all the benefits of the VPX backplane architecture," said David Dietz, vice president and general manager of Curtiss-Wright Controls Electronic Systems group.Sales Contact Please forward all sales and reader service inquiries to Curtiss-Wright Controls Electronic Systems Tel: (661) 257-4430 email: Email Contact Editorial Contact For editorial information regarding Curtiss-Wright Controls Electronic Systems, contact John Wranovics Public Relations Director Curtiss-Wright Controls Tel: (925) 640-6402 email: Email ContactThis fully-featured intelligent power supply supports Built-in Tests (BIT) and software programmability to enable rapid system development.CWCES Smart Power Supply Performance Features:About Curtiss-Wright Controls Electronic Systems Curtiss-Wright Controls Electronic Systems is one of the industry's most comprehensive and experienced single sources for rugged, integrated electronic system solutions. Our product and service expertise includes mission and flight control computer systems ; network centric computing systems; avionics and Vetronics processor units; motion control solutions and rate sensor assemblies; rugged high-speed data recorders and storage devices ; engineered packaging (including chassis/enclosures, power supplies, subracks and backplanes) ; smart power control and distribution systems ; sensor management systems ; electric turret drive, stabilization, and ammunition handling systems; and electro-mechanical solutions . The Electronic Systems group serves the defense, aerospace, commercial and industrial markets and is part of Curtiss-Wright Controls Inc. For more information about Curtiss-Wright Controls Electronic Systems, visit www.cwcelectronicsystems.com .3U VPX (VITA 48.2/62) form factor Up to 279W total rated power 80% efficiency 18-36 VDC input range MIL-STD-704 and MIL-STD-1275 compliant Meets NAVSO P-3641 de-rating Internal holdup up to 50 ms EMI/RFI input filter (MIL-STD-461E) Input transient (surge) protection Input reverse polarity protection Over/under voltage, short-circuit and under/over temperature protection White Sand Missile Range (WSMR)-tested Nuclear Event Circumvention circuit On-board ARM-based microcontroller I2C communication Inline voltage/current monitoring and BIT Suitable for OpenVPX and VPX systems Custom power sequencingFor additional product information on the 3U OpenVPX power supply and to download the factsheet, please visit: http://www.cwcelectronicsystems.com/3u_vpx_powersupply.html

Sales Contact Please forward all sales and reader service inquiries to Curtiss-Wright Controls Electronic Systems Tel: (661) 257-4430 email: Email Contact Editorial Contact For editorial information regarding Curtiss-Wright Controls Electronic Systems, contact John Wranovics Public Relations Director Curtiss-Wright Controls Tel: (925) 640-6402 email: Email Contact

Landauer, Inc. Declares Regular Cash Dividend

GLENWOOD, Ill., Aug. 26, 2011 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.55 per share for the fourth quarter of fiscal 2011. The dividend will be paid on October 4, 2011, to shareholders of record on September 9, 2011.

SOURCE Landauer, Inc.Landauer is a leading global provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. The Company provides its dosimetry services to approximately 1.6 million individuals globally. In addition, through its Global Physics Solutions subsidiary, the Company provides therapeutic and imaging physics services to the medical physics community.

SOURCE Landauer, Inc.

Cool Down with Volvo Radiators

Behind the Volvo�s distinctive grille lies the Volvo radiator, more known in its function to be the heart of the engine�s cooling system. This happens when engine coolant works through the radiator that all the excess heat is removed safely.

Your Volvo radiator has a tank on each side. Inside this tank is a transmission cooler. This transmission cooler is like a radiator within a radiator, except, of course, when instead of exchanging heat with the air, the oil exchanges heat with the coolant in the radiator.However, due to natural wear and tear or damage due to corrosive elements that could happen to make its way to your Volvo radiator, you may find your Volvo radiator wanting to be replaced. You may actually notice it giving you signals telling you to find a replacement.Parts and accessories for your Volvo like your Volvo radiator are made available by http://www.carpartsone.com. A wide array of Volvo radiators is available 24 hours a day for interested Volvo owners. Volvo radiators would actually give your Volvo better and enhanced performance. Plus, you would have peace of mind that your Volvo would not heat up on you.The Volvo radiator is a type of heat exchanger designed to transfer heat from the hot coolant that flows through it to the air blown through it by the fan. Most Volvo radiators are made of aluminum, made by brazing thin aluminum fins to flattened aluminum tubes. The coolant then flows from the inlet to the outlet through many tubes mounted and arranged in a parallel pattern. The fins conduct heat from the tubes and then transfer it to the air flowing through the radiator.

Volvo radiators have been manufactured to ensure consumers quality, durability, and reliability. They certainly have been tried and tested to guarantee a cool ride in your Volvo.

Help at hand for the DIY 'dunces'

A COMBINATION of increasingly hectic lifestyles - and laziness - is turning us into a nation of DIY 'dunces'.

Research by the leading practical website, Comerco.com claims 3.5m men admit to finding it difficult to put up shelves, while 3.7m wouldn't know how to bleed a radiator.* For more information, visit the website: www.comerco.com or phone 0121 454 9707.Bal Mattu, the site's founder, says while our dads and grandads would have willingly rolled up their sleeves to get the job done, many of us would now rather call in a professional than carry out the work ourselves.The main advantage of Comerco.com is that it removes the need to hunt around for the best tradesman and at the same time protects you against rogue traders.

* For more information, visit the website: www.comerco.com or phone 0121 454 9707.

Rogue Dealers In Cast Iron Radiators

Buyer bewares when purchasing a cast iron radiator. As cast iron radiators have risen in popularity many companies and individuals have joined the band wagon for �a fast buck�. Amongst the genuine of us, this has become a disconcerting problem within the industry as competition for the market place has become fierce.

Rogue dealers within the reproduction cast iron radiator market can also cause problems especially when you find that your newly installed radiator leaks. A professional dealer should have furbished you with clear lifting instructions prior to delivery and installation as improper handling of the radiator can cause leaks. Once leaks have occurred disreputable dealers will, after much argument, only offer you back the money for the radiator and leave you with the problem of finding another radiator the same size as your pipe work.Pitfalls there are, like in many purchases we make in life, however with a little care and knowledge you can purchase cast iron radiators with confidence of good product and service from reputable dealers.Also beware of dealers who quote that they are British Standard tested for quality and efficiency, many are not and you may find that the heat output they proclaim for the radiator is greater than it should be leaving you short of heat when you really need it. You will only find this a problem after installation when you experience a cold snap and the room will not heat sufficiently. If you are unsure of an advertised heat output, particularly with internet marketing, you can compare different sites for the same reproduction radiator and those sites which advertise the highest output per section of cast iron radiator are usually misleading you. Also it is known that some companies selling old original cast iron radiators proclaim they are British Standard tested, this is impossible as it is difficult to believe that each individual old radiator has been taken to the British Standard testing office and been tested, at great expense, before sale.A good reputable dealer will undoubtedly offer a full radiator calculator service to ensure that you are getting the correct BTU for the rooms that they are to be fitted.

Pitfalls there are, like in many purchases we make in life, however with a little care and knowledge you can purchase cast iron radiators with confidence of good product and service from reputable dealers.

Princeton Security Technologies (OTCBB: PSGY) Continues Strong Performance in August With Sales of Radiation Isotope Identifiers Leading the Way

Princeton Security Technologies, Inc. (OTCBB: PSGY), a leading developer of Gamma-ray and X-ray Detectors and Spectroscopy systems, serving a broad customer base in homeland security, scientific research, industrial materials analysis, completes August with a strong growth trend increasing sales backorders to exceed $1.6M.

Over half of the company's revenue is accrued through steady sales in Radiation Isotope Identifiers (RIID). Other recent benchmarks that drove business include the completion of a custom radiation detection package for iRobot™ UUV, and production of the first commercially available dual scintillator radiation monitoring package capable of detecting both gamma and neutron radiation energy. The majority of the current orders are on schedule to ship in Q3 and into Q4 FY11.About Princeton Security Technologies Inc.: Princeton Security Technologies, through its wholly owned subsidiary, Princeton Gamma-Tech Instruments, Inc (PGT), is a supplier of X-ray and Gamma-ray Detectors, Spectroscopy systems, Radiation Detection Area Monitors and Radioactive Radioisotope Identifier products. The Company serves a broad customer base in scientific research, industrial materials analysis, and Homeland Security. PGT has its headquarters with highly skilled R&D and manufacturing staff in its Princeton facility.Contact: Howard Isaacs (562)987-4939 Email Contact

Contact: Howard Isaacs (562)987-4939 Email Contact

Aeolus Pharmaceuticals' Announces Presentation of AEOL10150 Data at the 14th International Congress of Radiation Research

Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company that is leveraging up to $140M of government funding in developing a platform of a new class of broad-spectrum catalytic antioxidant compounds as medical countermeasures to radiation exposure to develop them in oncology indications, today announced data from its proof of principle study conducted in a non-human primate model of Pulmonary Acute Radiation Syndrome (ARS) were presented at the 14th International Congress of Radiation Research in Warsaw, Poland.

About AEOL 10150The primary objective of the study was to determine whether post-exposure administration (24 hours) of AEOL 10150 could mitigate radiation-induced lung injury and enhance survival in rhesus macaques exposed to WTLI and administered supportive care. Two cohorts of NHPs (total n=13) were exposed to 11.5Gy LINAC-derived photon radiation in the WTLI protocol. The control cohort had n=6 and AEOL-treated cohort was n=7. This model showed 100% incidence of severe radiation-induced lung damage. AEOL 10150 was administered subcutaneously at 5mg/kg beginning at day 1 post WTLI and continued as a single, daily injection for 28 consecutive days.5. The results of this pilot study are encouraging and suggest that treatment with AEOL-10150 results in reduced clinical, radiographic and anatomic evidence of radiation-induced lung injury, which resulted in improved survival. AEOL-10150 merits further study as a post-exposure MCM against radiation-induced lung injury.AEOL 10150 has now demonstrated a survival advantage in two species of animals exposed to lethal doses of radiation: the mouse and the NHP, which is a requirement for approval by the Food and Drug Administration under its Animal Rule. The Company was awarded a contract valued up to $118 million by the Biomedical Advanced Research and Development Authority (BARDA) for the development of the compound as a medical countermeasure against the effects of radiation exposure on the lungs in February 2011. As part of this contract Aeolus is currently conducting studies to determine the LD30/180, LD50/180, and LD70/180 in both species in the Whole Thorax Lung Irradiation (WTLI) model.Contact: Russell Skibsted Sr. Vice President and Chief Financial Officer Aeolus Pharmaceuticals, Inc. 1-(949) 481-98252. AEOL-10150, as administered in this pilot study (daily on d1-28 at 5mg/kg SC), demonstrated potential efficacy as a mitigator against fatal radiation-induced lung injury. Treatment with the drug resulted in 28.6% survival following exposure to a radiation dose that proved to be 100% fatal in the untreated control group.AEOL 10150 is a broad-spectrum catalytic antioxidant specifically designed to neutralize reactive oxygen and nitrogen species. The neutralization of these species reduces oxidative stress, inflammation, and subsequent tissue damage-signaling cascades resulting from radiation exposure. AEOL 10150 could have a profound beneficial impact on people who have been exposed, or are about to be exposed, to high-doses of radiation in the treatment of oncology. AEOL 10150 has already performed well in preclinical and non-clinical studies, was well-tolerated in two human clinical trials, and has demonstrated statistically significant survival efficacy in an acute radiation-induced lung injury model. The Company believes it could have a profound beneficial impact on people who have been exposed, or are about to be exposed, to high-doses of radiation, whether from cancer therapy or a nuclear event.Forward-Looking Statements4. Dexamethasone administration yielded a transient benefit on both clinical and radiographic evidence of pneumonitis. The AEOL-10150 treated cohort required 1/3 less dexamethasone support due to reduced pulmonary injury in the AEOL-10150 treated group, resulting in less frequent clinical "triggers" (respiratory rate ≥ 80) to treat with dexamethasone.Aeolus Pharmaceuticals is developing a new class of catalytic antioxidant compounds that protects healthy tissue from the damaging effects of radiation. Its first compound, AEOL 10150, is being developed for oncology indications, where it is used in combination with radiation therapy. It is also being developed, with funding by the US Government, as a medical countermeasure against chemical and radiological weapons, where its initial target indications are as a protective agent against the effects of acute radiation syndrome and delayed effects of acute radiation exposure. Aeolus' strategy is to leverage the substantial investment in toxicology, manufacturing, and preclinical and clinical studies made by US Government agencies in AEOL 10150, including the contract with BARDA valued, with options, at up to $118 million, to efficiently develop the compound for use in oncology.The statements in this press release that are not purely statements of historical fact are forward-looking statements. Such statements include, but are not limited to, those relating to Aeolus' product candidates, as well as its proprietary technologies and research programs. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Aeolus' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Important factors that could cause results to differ include risks associated with uncertainties of progress and timing of clinical trials, scientific research and product development activities, difficulties or delays in development, testing, obtaining regulatory approval, the need to obtain funding for pre-clinical and clinical trials and operations, the scope and validity of intellectual property protection for Aeolus' product candidates, proprietary technologies and their uses, and competition from other biopharmaceutical companies. Certain of these factors and others are more fully described in Aeolus' filings with the Securities and Exchange Commission, including, but not limited to, Aeolus' amended Annual Report on Form 10-K/A for the year ended September 30, 2010. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.3. Serial CT scans demonstrated less quantitative radiographic injury (pneumonitis, fibrosis, effusions) in the AEOL-10150 treated cohort suggesting that the drug reduces the severity of the radiographically detectable lung injury.1. Exposure of the whole thorax to 11.5 Gy resulted in radiation-induced lung injury in all Non-Human Primates (NHP) in the study and proved 100% fatal in the control animals, despite supportive care including dexamethasone. 11.5 Gy is, therefore, equal to or greater than the LD100/180 dose for the Whole Thorax Lung Irradiation (WTLI) model.The primary endpoint of the study was mortality. Secondary endpoints included respiratory rate (RR), oxygen saturation of peripheral blood (SpO2), and radiographic lung injury as quantified on serial CT scans. The results showed that 2 out of 7 animals in the AEOL 10150 treated group survived, compared to 0 out of 6 animals surviving in the control group. Radiographic analysis demonstrated that, on average, the AEOL 10150 treated animals 28 percent less volume of pneumonitis and fibrosis than the control animals. RR and SpO2 data reflected greater radiation induced lung injury in the control group and correlated with the lung injury and survival data.Key findings in the study include:

Contact: Russell Skibsted Sr. Vice President and Chief Financial Officer Aeolus Pharmaceuticals, Inc. 1-(949) 481-9825

Designer Radiators: How to Choose the Best Ones for your Home

If you're planning on installing or upgrading a central heating system, perhaps beautifying your home is the last thing on your mind. But when you visit your online radiator showroom you're in for a big, pleasant surprise. For today�s designer radiator is a thing of beauty as well as a device to warm up your home. Here are some tips on choosing the best designer radiator for your home.

However, the responsiveness of aluminium radiators combined with their low water content translates into excellent cost efficiency which means lower bills for you. What's more, aluminium radiators are very light and easy to install. This often means lower installation fees. Ultimately, the choice of material is yours. Each has its own benefits, but aluminium wins out for its blend of function, beauty and economy.The first thing to consider is the existing decor of your home and how your new designer radiators ( http://www.RadiatorShowroom.com )will fit in terms of space and colour. Beauty depends on harmony so you'll need to find radiators that fit. You have to consider such matters as colour and the contours and space of your rooms. Fortunately with designer radiators, you have infinite choice of style and colour.If you've decided to enhance the beauty and value of your home by adding or replacing designer radiators, it's time to look at some designs online. Browsing at online designer radiator showrooms makes the whole process easy and convenient. Choose some designs and colours that you feel will suit your home. Then call the showroom to discuss such practicalities as availability, pricing and delivery times and procedures. Then, get ready to transform your home in something special � a snug abode that�s also the height of style. And it�s all done with the wonder of designer radiators.The next thing to consider is the material your new designer radiators ( http://www.RadiatorShowroom.com/designer-radiators.html)are made of. The best options are stainless steel and aluminium. Both are extremely efficient heat conductors and both have very attractive finishes. However there are some differences. Aluminium is a super conductor. This makes it extremely responsive to your control. Your house warms up quickly when you turn on your central heating. It also cools down just as quickly when you turn it off. Stainless steel radiators retain heat a little longer. Both materials are easy to clean, you just need to wipe them down with warm water and detergent a few times a year.

If you've decided to enhance the beauty and value of your home by adding or replacing designer radiators, it's time to look at some designs online. Browsing at online designer radiator showrooms makes the whole process easy and convenient. Choose some designs and colours that you feel will suit your home. Then call the showroom to discuss such practicalities as availability, pricing and delivery times and procedures. Then, get ready to transform your home in something special � a snug abode that�s also the height of style. And it�s all done with the wonder of designer radiators.

Why Choose Designer Radiators?

There are a good number of reasons to choose designer radiators with which to heat the home. Heating is an absolutely fundamental part of any home and so why have something unattractive and bulky when you could have something sleek and nice to look at? There are plenty of designer radiators to choose from in the modern age as more and more people are looking for a stylish and unique alternative to the standard radiator of days gone past. This article provides information as to why designer radiators are a good choice in any home. Read on to find out more.

When it comes to heating there are plenty of options to choose from. Dimplex storage heaters are an economical way to heat the home as they are warmed through the night when electricity is cheaper and release the heat slowly during the day to warm the home. This works very well to heat the home whilst saving money. Designer radiators are a good choice for anyone wanting a unique style or a radiator that fits in well with the rest of the decor in the room. Water filled radiators, oil filled radiators and electric varieties are all available. Budget, requirements and personal style will all play a role in which type and model you buy for your home.Some radiators truly look like works of art. Sometimes you can't even see what it is until you are up close and can feel the warmth. Instead of purchasing art or furniture to fill a room, why not select a designer radiator of some kind? Not only will it provide aesthetic appeal but it will heat the room too.Some homes have irregular shaped rooms or small alcoves and spaces that would be perfect for a radiator but cannot have a normal shaped one as there is no room. Having a specially designed radiator is ideal in these cases. You can have them made to fit precisely into the space you have available. Designer radiators are a fantastic solution for this.There is no end to the creativity and ingenuity that designer radiators incorporate. We have all come across heated towel rails - they not only look nice and warm the room but they also provide a warm towel for you to use after a shower. This is extremely luxurious and can be a real blessing in mid-winter! There are also designer radiators that incorporate a mirror and are designed to be fitted to the wall. This means there is a heat source in the morning to warm you as you put on makeup or choose an outfit in the morning. This ensures getting out of bed is not so difficult when it is dark and frosty outside as you know you will soon be warm and toasty!

When it comes to heating there are plenty of options to choose from. Dimplex storage heaters are an economical way to heat the home as they are warmed through the night when electricity is cheaper and release the heat slowly during the day to warm the home. This works very well to heat the home whilst saving money. Designer radiators are a good choice for anyone wanting a unique style or a radiator that fits in well with the rest of the decor in the room. Water filled radiators, oil filled radiators and electric varieties are all available. Budget, requirements and personal style will all play a role in which type and model you buy for your home.

Dr DIY

HOW TO..

2.Make a mark on the wall where you need to fix your brackets, remembering to measure the distance between the brackets already fixed to the back of the radiator.Hang a radiator I HATE to say it, but winter's not too far round the corner. So if your central heating system needs some work, now's the time to start thinking about it. It's an expensive business... but you can save money by hanging a radiator yourself so it's all ready to be plumbed in by a professional.All power tools kindly supplied by Ryobi Power Tools: www.ryobitools.co.uk www.craigphillips.co.uk3. Use your hammer action drill driver and an 8mm masonry drill bit, to drill into the wall. Then insert your wall plugs by hand. Firmly screw the brackets to the wall. Use a spirit level to check the position of the brackets. 4. The radiator will be heavy, so get a strong friend to help you lift your radiator on to the brackets. 5. Finally, all you need to do is book your plumber in to make the quick connection to your pipework and your home is ready.Tools and materials: 18v hammer action drill driver 8 mm masonry drill bit Spirit level Tape measure Radiator, brackets and fixing 1.Start by finding a suitable location for your new radiator, then you can decide what size to purchase. If you are just replacing your radiators, try to install them as close to existing pipe work as possible. You can choose between a single or double radiator, ranging from 300 to 3,000mm wide and 400 to 1,000mm high.

All power tools kindly supplied by Ryobi Power Tools: www.ryobitools.co.uk www.craigphillips.co.uk